We previously identified a novel transcript, mouse (m)IL-20R1a, generated by alternative splicing of the mIL-20R1 gene and studied its possible in vitro functions. However, the function of mIL-20R1a in vivo is unknown. Overexpression of mIL-20R1a in transgenic FvB/N mice resulted in the pathological change of excess calcium deposited in the kidneys. The interplay between renal epithelial cells and calcium oxalate (CaOx) was important in the crystallization involved in the formation of renal stones (nephrolithiasis). Thus, we investigated and compared the responses of mouse renal proximal (TKPTS) and collecting (M-1) tubule cell lines to CaOx with or without mIL-20R1a. The renal epithelial cell lines exposed to CaOx in the presence of mIL20R1a showed significantly increased lactate dehydrogenase release; loss of cell viability through apoptosis; increased CaOx internalization; higher tumor necrosis factor (TNF)-a, MCP-1 and RANTES expression; and higher reactive oxygen species production. Interleukin-6, TNF-a and MCP-1 were also upregulated in the kidneys of mIL-20R1a transgenic mice. These effects of mIL-20R1a on CaOx-exposed renal epithelial cells showed that mIL-20R1a functioned as an aggravating factor in promoting calcium deposition in kidney of mice.
Introduction
The interleukin (IL)-10 family was defined after the discovery of several IL-10-related cytokines, including IL-19, 1 IL-20, 2 IL-22, 3 IL-24 4 and IL-26. 5 Within this subfamily, IL-19, IL-20 and IL-24 share receptor complexes; 6 all of them are capable of signaling through IL-20R1/IL-20R2 and IL-20 and IL-24 can also use IL-22R/ IL-20R2. 6 Because a growing number of studies have revealed the association of IL-19, 7-9 IL-20 8, [10] [11] [12] [13] [14] [15] [16] and IL-24 [17] [18] [19] [20] [21] [22] with diseases, the identification of soluble proteins derived from the genes of the functional receptors may provide more insights into the biomolecular mechanisms of their functions.
Our recent study has identified a novel soluble protein, mouse (m)IL-20R1a, generated by alternative splicing of the mIL-20R1 gene, which encodes one subunit of the receptor complex for mIL-19, mIL-20 and mIL-24. mIL-20R1a encoded a soluble form of mIL-20R1 without a transmembrane domain. However, no significant interaction between mIL-20R1a and mIL-19 or mIL-20 was detected. 23 This soluble protein can act on mesangial cells directly and result in phosphorylation of AKT and C-Jun N-terminal kinase (JNK). In addition, mIL-20R1a may stimulate the production of chemoattractants, renal fibrogenic factors and reactive oxygen species (ROS) by mesangial cells. 23 These mIL-20R1a-mediated effects on mesangial cells could be amplified through increased transcription of mIL-20R1a by angiotensin II, platelet-derived growth factors and lipopolysaccharide (LPS), important mediators involved in the pathogenesis of lupus nephritis. Furthermore, elevated mIL-20R1a in splenocytes of SLE-prone mice promoted stimulated splenic B cells to produce more IL-10. 23 The in vitro study showed the possible biological roles of mIL-20R1a in lupus nephritis. 23 Besides exploring the involvement of mIL-20R1a in the pathogenesis of lupus nephritis, we also sought to investigate the in vivo function of mIL-20R1a. Generation of transgenic mice and knockout mice are two common strategies used to study the in vivo function of a novel gene. mIL-20R1a was generated by alternative splicing of the same gene with membrane-form receptor, mIL-20R1. The expression of mIL-20R1 may also be abolished in mIL-20R1a knockout mice. Therefore, we generated mIL-20R1a transgenic mice to explore its in vivo biological functions and specify the possible association with diseases.
Calcium oxalate (CaOx) crystals are the major constituents of most human urinary stones. 24 The mechanism of CaOx stone formation is complex and many factors are involved. The intratubular growth, aggregation and retention of crystals are considered essential for the development of kidney stones. 25 The attachment of crystals to injured renal epithelium is thought to be a necessary event in the initiation of kidney stones. 26 Exposure to high levels of CaOx crystals is injurious to renal epithelial cells and leads to both apoptosis and necrosis. 27 Furthermore, crystal deposition is often associated with inflammation. 28 Diverse inflammatory cells migrating to the adjacent interstitium are important in renal tissue damage. 28 CaOx-induced peroxidative injury because of ROS production is one major mechanism that promotes crystal attachment to renal epithelial cells. 29 Calcium-induced injury exposes the basolateral membrane, which often becomes the site of an anchored aggregation of crystals. 30 Once adherent, crystals can be internalized and transcytosed to the interstitium, where they grow and nucleate.
In this study, our pathological studies of mIL-20R1a transgenic mice revealed this gene's association with renal stone formation (nephrolithiasis). Our in vitro experiments also supported the detrimental role of mIL-20R1a in the CaOx-mediated cell responses involved in the pathogenic mechanisms of renal stone formation.
Results
Overaccumulated calcium in the renal tubules of mIL-20R1a transgenic mice To explore the biological function of mIL-20R1a in vivo, we developed the mIL-20R1a transgenic mice, and a USA board-certified animal pathologist analyzed their overall pathophysiological phenotypes. Using enzymelinked immunosorbent assay, we found a higher serum level of mIL-20R1a in transgenic mice (18.1±7.8 ng ml À1 ) than in control mice (3.8 ± 1.3 ng ml
À1
), showing that mIL-20R1a was a secreted protein. There were excess deposits in the renal tubules of mIL-20R1a transgenic mice (Figures 1a and b) , but not in those of control mice (Figure 1c ). Some moderately dilated cortical tubules contained basophilic granular material consistent with mineralizing protein-filled fluid in kidneys of transgenic mice. This pathological change is essential for forming kidney stones in humans. In addition, to confirm whether the deposits contained CaOx, the major constituents of most human urinary stones, 24 we performed Pizzolato staining on kidney tissue sections from control and mIL-20R1a transgenic mice. The results revealed that the basophilic granular material in dilated cortical tubules in kidneys of transgenic mice was composed of CaOx-containing protein (data not shown).
Renal function was assessed by measuring the elevation in plasma levels of creatinine. We found a higher serum level of creatinine in transgenic mice (2.75 ± 1.4 mg per 100 ml) than in control mice (0.8±0.3 mg per 100 ml). Physical examination showed no altered serum concentrations of calcium, phosphate, magnesium, uric acid or pH in transgenic mice compared with those in control mice (Table 1 ). In addition, we also analyzed the factors that are involved in CaOx crystal formation. Urine concentrations of calcium, oxalate, citrate or pH were not altered in transgenic mice compared with those in control mice (data not shown). As mineral metabolism in mIL-20R1a transgenic mice was not different from that in control mice, we further explored, both in vitro and in vivo, how mIL-20R1a overexpression contributed to these calcium deposits.
mIL-20R1a increased CaOx-induced signals in renal epithelial cells Calcium oxalate-induced activation of p38 mitogenactivated protein kinase (p38-MAPK), JNK and extracellular signal-regulated kinase (ERK) in renal epithelial cells leads to the upregulation of several vital genes and proteins associated with nephrolithiasis. [31] [32] [33] To determine whether mIL-20R1a increases CaOx-induced signaling, we analyzed two renal epithelial cell linesmouse renal proximal (TKPTS) and collecting (M-1) tubule cell lines-using signal-transduction assays. Pretreatment with mIL-20R1a alone for 1 h phosphorylated ERK, p38-MAPK and JNK in M-1 cells but not in TKPTS cells (Figure 2 ). mIL-20R1a treatment increased CaOxinduced phosphorylation of p38-MAPK, JNK and ERK in particular in M-1 cells (Figure 2 ). mIL-20R1a treatment in Detrimental roles of mIL-20R1a in calcium deposits C-C Wei and M-S Chang TKPTS cells amplified only CaOx-mediated ERK activation ( Figure 2 ). To facilitate expression and purification of mIL-20R1a, it was fused with a fusion protein, maltosebinding protein (MBP). Thus, MBP was used as a negative control for mIL-20R1a. MBP and heat-denatured mIL-20R1a protein did not induce significant signals, ruling out the effect of MBP and any potential trace amount of LPS in the recombinant protein (data not shown). This indicated that the activity was specific for mIL-20R1a.
mIL-20R1a increased CaOx-induced cell injury of renal epithelial cells Renal epithelial cells with calcium crystal deposits are often injured. 28 . Transgenic mice showed that the overexpression of mIL-20R1a facilitated the accumulation of calcium in renal tubules. Our signal-transduction findings showed that two mouse renal epithelial cells were appropriate targets for studying the involvement of mIL20R1a in renal calcium deposition. To explore the molecular mechanism through which mIL-20R1a was involved in the pathogenesis of calcium deposition leading to nephrolithiasis, we treated renal epithelial cells in vitro with mIL-20R1a alone, CaOx alone or mIL20R1a plus CaOx. Lactate dehydrogenase (LDH) release into the medium, an indicator of cell injury, was higher in all treated M-1 and TKPTS cells than in untreated ones.
The LDH levels in medium of all treated cells timedependently increased (Po0.05) (Figure 3 ). In addition, the LDH release was significantly higher in M-1 and TKPTS cells treated with CaOx and mIL-20R1a than those treated with either CaOx or mIL-20R1a only (Po0.05) (Figure 3 ). MBP and heat-denatured mIL20R1a protein did not induce significant cell injury (data not shown). ) with or without mIL-20R1a pretreatment as indicated. Cell lysates were isolated and the levels of phospho-ERK1/2 (Tyr 204), phospho-p38 (Thr-180/Tyr-182) and phospho-JNK were detected using western blot with specific antibodies. b-actin was an internal control. Similar results were obtained in three independent experiments. One representative result of the three is shown.
Detrimental roles of mIL-20R1a in calcium deposits C-C Wei and M-S Chang mIL-20R1a increased CaOx adhesion and endocytosis in renal epithelial cells Crystal retention in the kidney is caused by the interaction between crystals and the cells lining the renal tubules. These interactions involve crystal attachment and then internalization. We therefore studied the ability of various renal epithelial cell lines to internalize CaOx crystals with or without mIL-20R1a treatment. A flow cytometric assay showed that both M-1 and TKPTS cells had endocytosed CaOx crystals ( Figure 5 ). mIL-20R1a- 
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C-C Wei and M-S Chang treated M-1 and TKPTS cells endocytosed more CaOx crystals than untreated cells did. We found significant (Po0.05) dose-dependent effects on calcium attachment and internalization in both cell types after mIL-20R1a treatment ( Figure 5 ). The MBP and heat-denatured mIL20R1a protein showed no effect on calcium adhesion to these two cells (data not shown).
mIL-20R1a treatment of renal epithelial cells increased CaOxinduced ROS production
Reactive oxygen species production partially mediates CaOx crystal-induced damage to renal epithelial cells and various cellular responses. 35 Treatment with mIL20R1a and CaOx alone caused ROS production in M-1 ( Figure 6a ) and TKPTS cells (Po0.05) (Figure 6b ).
Treatment with both CaOx and mIL-20R1a together caused significantly more ROS production (Po0.05). No obvious ROS production was detected in cells treated with 10 ng ml À1 of LPS, and CaOx-induced ROS generation was not increased by treatment with heat-denatured mIL-20R1a and MBP (data not shown).
mIL-20R1a upregulated nephrolithiasis-associated cytokines and chemokines in renal epithelial cells Increasing evidence shows the involvement of inflammatory and immune responses in both experimental stone-disease models and in kidneys from patients with acute and chronic oxalosis. 28 In response to CaOx exposure, renal epithelial cells produce a variety of cytokines and chemoattractants to recruit immune (Figures 7a and b) , whereas IL-6 transcripts were increased only in mIL-20R1a-treated TKPTS cells (Po0.05) ( Figure 7B ). The expression of TNF-a, MCP-1 and RANTES in CaOx-exposed M-1 cells and that of IL-6, TNF-a, MCP-1 and RANTES in CaOx-exposed TKPTS cells further increased after 4 h of mIL-20R1a treatment (Po0.05) (Figure 7a and b) . MBP and heat-denatured mIL-20R1a had no effect on the expression of these molecules (data not shown), which indicated that increased expression was a specific response to mIL-20R1a.
IL-6, TNF-a and MCP-1 were upregulated in the kidneys of mIL-20R1a transgenic mice mIL-20R1a treatment upregulated the expression of proinflammatory cytokines and chemoattractants in CaOx-exposed renal epithelial cells in vitro. Our realtime-PCR result revealed that the expression of mIL20R1a was indeed higher in the kidney of transgenic mice than that in control mice (Po0.05) (Figure 8a ). We further investigated whether mIL-20R1a would similarly affect the expression of these molecules in vivo. We used real-time-PCR with specific primers and IHC staining with anti-MCP-1 antibodies to analyze the kidneys of mIL-20R1a transgenic mice and control mice. mIL-20R1a did indeed upregulate IL-6, TNF-a and MCP-1 in the kidneys of mIL-20R1a transgenic mice (Po0.05) (Figure 8b ). The increased production of MCP-1 in the kidneys of transgenic mice was further confirmed using IHC staining (Figure 8c ).
Discussion
In this study, we found that mIL-20R1a transgenic mice had excess calcium accumulation in their renal tubules. Both in vitro and in vivo assays confirmed the potential role of mIL-20R1a in calcium deposits associated with the pathogenesis of renal stone formation. Although not all mIL-20R1a transgenic mice developed renal calcium deposition, these mice could still serve as a useful model for studies not only on kidney stones but also on lupus nephritis. 23 We found other pathological changes in procreation and hematopoiesis in these transgenic mice (data not shown). Further studies are necessary to clarify whether mIL-20R1a is involved in the pathophysiological events that underlie procreation-or hematopoiesis-related diseases. 
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The interaction between CaOx and the renal tissues results in changes of cell function to promote the crystallization essential for renal stone formation. Our in vitro studies were conducted using tissue cultures from two renal epithelial cell lines derived from proximal tubules and collecting ducts. mIL-20R1a had similar effects on cell injury, apoptosis and crystal attachment and endocytosis in both types of cells. However, these Detrimental roles of mIL-20R1a in calcium deposits C-C Wei and M-S Chang two renal epithelial cell lines responded differently to the same treatment in signal transduction and the expression of crystallization modulators, which suggested that these two cell types may contribute differently to renal calcium deposits.
Only pathological changes in the kidney, including renal injury and dysfunction, permit crystal retention, which eventually leads to kidney stone formation. Treating renal epithelial cells with CaOx plus mIL20R1a produced greater cell injury. This finding confirmed our hypothesis that mIL-20R1a promotes the accumulation of calcium in the kidneys by increasing CaOx-induced epithelial cell injury. Furthermore, mIL20R1a treatment alone damaged renal epithelial cells; such damage is also the key element involved in other renal diseases, such as acute and chronic renal failure, 39 septic shock 40 and hemolytic uremic syndrome. 41 Therefore, we postulated that mIL-20R1a may also be involved in the pathogenesis of other renal diseases characterized by epithelial cell injury.
Apoptotic changes observed in renal epithelial cells induced by massive CaOx crystals might result in cell degradation and play a role in the pathologic course of nephrolithiasis. 42 Treatment with mIL-20R1a alone or CaOx alone resulted in apoptosis in our two renal epithelial cell lines. mIL-20R1a-induced apoptosis may lead directly to cell death and account for the elevated levels of LDH released from injured cells. Greater injury to mIL-20R1a plus CaOx-treated cells may be caused by other mIL-20R1a-mediated effects that disrupt cell integrity, such as the generation of ROS or proteolytic enzymes but not cell apoptosis.
In addition to increasing CaOx-induced cell injury, mIL20R1a treatment affected crystal adhesion and internalization in renal epithelial cells. The attachment of CaOx to the apical surface of renal tubular epithelium, and subsequent crystal internalization, is an important early event in the formation of kidney stones. 26 Therefore, we hypothesized that mIL-20R1a and CaOx act together on renal epithelium to expose more sites for crystal attachment due to their additive effect on cell damage. mIL-20R1a treatment increased CaOx-induced ROS production in renal epithelial cells, especially in CaOxexposed TKPTS cells, which increased CaOx-induced injury in renal epithelial cells, as indicated by the release of LDH. In addition, treatment with mIL-20R1a alone induced ROS generation in not only both types of renal epithelial cells but also mesangial cells. 23 It has been well established that ROS generation is involved in many kidney diseases. [43] [44] [45] Therefore, mIL-20R1a may also participate in the progression of other renal diseases through ROS production.
mIL-20R1a and CaOx each induced the expression of proinflammatory cytokines and chemokines, and combining them upregulated that expression. Stimulated epithelial cells and mesangial cells 23 may release a variety of cytokines, chemokines and growth factors to promote further inflammation. Furthermore, local renal inflammation is involved in many renal pathologies other than nephrolithiasis, such as various forms of nephritis and nephropathy 46 and acute renal failure, 47 as well as transplant rejection. 48 Thus, some mIL-20R1a-triggered cytokine and chemokine production in renal cells may be involved in other inflammation-associated renal diseases.
The in vitro and in vivo functional studies of mIL-20R1a showed its association with different renal diseases. mIL20R1a induced different intracellular signaling in two kinds of target cells, renal epithelial cells and mesangial cells. 23 However, both cells produced higher level of chemokines and ROS in response to mIL-20R1a treatment. 23 Other mIL-20R1a-mediated effects on renal epithelial cells including cell apoptosis and calcium internalization were not observed in mesangial cells (data not shown). In addition, experimental disease model can be applied on mIL-20R1a transgenic mice to further clarify the involvement of mIL-20R1a in lupus nephritis.
In conclusion, we have identified mIL-20R1a and discovered its association with renal calcium deposition involved in nephrolithiasis. We speculate that in a supersaturated urine environment in vivo, mIL-20R1a, directly or indirectly, or both, damages epithelial cells in renal tubules by increasing cytokine and ROS production, which exposes more crystal-binding sites on cell surfaces and eventually leads to excess calcium deposits. We believe that all of these events promote calcium deposition independently or else form a positive loop to amplify their effects on calcium accumulation. The detrimental roles of mIL-20R1a in calcium deposits in the progress of kidney stone formation suggests that combined therapy, including intervention to stop IL20R1a-mediated effects, may offer new therapeutic potential.
Materials and methods

Cell culture
Two renal epithelial cell lines were used: M-1 from mouse kidneys, which represented collecting ducts, and TKPTS cells, which represented proximal tubular cells. The M-1 cell line derived from the cortical collecting duct microdissected from a transgenic mouse for the early region of SV40 (strain Tg(SV40E)Bri7). M-1 cells were purchased from the American Type Culture Collection (ATCC no. CRL-2038; Rockville, MD, USA). The TKPTS cell line is an immortalized mouse proximal tubule epithelial cell line developed and kindly provided by Dr Elsa Bello-Reuss. 49 Cells were cultured as previously described. 50 Expressing and purifying the full-length and specific polypeptide of mIL-20R1a recombinant proteins in Escherichia (E.) coli The full-length of mIL-20R1a (Val  33 to Arg   105 , mIL20R1a), the specific polypeptide in mIL-20R1a (Ser 79 to Arg 105 , mIL-20R1a-SP) and MBP were expressed and purified as previously described. 23 A six-histidine tag was placed at the C terminus of the recombinant proteins. These proteins were used in the biological function analyses in vitro and to generate antibodies. MBP by itself was purified and used as a negative control in all in vitro assays. In addition, the mIL-20R1a was expressed in the E. coli host. To prove that the mIL20R1a-induced cellular responses were not the result of LPS endotoxin contamination of the recombinant protein, the protein was heat-denatured at 100 1C for 30 min, a condition under which LPS endotoxin is not destroyed.
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Generating polyclonal antibodies against mIL-20R1a We generated mIL-20R1a polyclonal antibodies for enzyme-linked immunosorbent assay by immunizing rabbits with purified mIL-20R1a-SP recombinant protein, following the standard protocol. The antibody was purified using protein-A affinity chromatography and used in enzyme-linked immunosorbent assay.
Developing mIL-20R1a transgenic mice A full-length transcript of mIL-20R1a with a histidine-tag at the 3 0 -end was cloned in an expression vector of pCDNA3.1. (Invitrogen Life Technologies, Carlsbad, CA, USA) driven by cytomegalovirus promoter. Twenty micrograms of mIL-20R1a plasmid DNA was linearized using restriction enzyme StuI (New England Biolabs, Beverly, MA, USA) and then phenol-chloroform extraction was done. Our transgenic mice were developed at the animal center in National Cheng Kung University, Tainan, Taiwan. All procedures were carried out with strict adherence to the NIH Guide for the Care and Use of Laboratory Animals and approved by the Animal Care and Use Committee of the animal center in National Cheng Kung University, Tainan, Taiwan. To select the mIL-20R1a transgenic mice, we analyzed genomic DNA by using PCR with certain primers. We performed enzyme-linked immunosorbent assay with anti-His antibody and anti-mIL-20R1a antibody to detect the serum level of mIL-20R1a in the mice. Samples for blood chemistry analysis from control and transgenic mice were evaluated by a central laboratory using standard procedures (Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan).
Pizzolato staining
The Pizzolato procedure was used to detect CaOx in the tissues. 51 Sections were deparaffinized and treated with 2.5% silver nitrate in 15% hydrogen peroxide solution and illuminated for 30 min, then rinsed with distilled water twice for 5 min each time. They were then counterstained with hematoxylin solution for 5 min. ) for 1 h. Cell lysates were separated using SDS-polyacrylamide gel electrophoresis. The levels of phospho-Stat3, phospho-Akt (Ser473), phospho-ERK1/2 (Tyr 204), phospho-p38 MAPK (Thr-180/Tyr-182), phospho-JNK and b-actin were detected using western blotting with specific antibodies (Cell Signaling Technology, Beverly, MA, USA).
Analyzing signal transduction
Lactate dehydrogenase assay
Lactate dehydrogenase is a stable cytosolic enzyme released when a cell is lysed or its membrane is injured. We treated M-1 and TKPTS cells (1 Â 10 6 per ml) with CaOx (133.4 mg cm
À2
) with or without mIL-20R1a (200 ng ml
À1
) for the times indicated. Conditioned medium was collected from the experimental wells and assayed for LDH activity after centrifugation. A colorimetric assay kit (Promega, Madison, WI, USA) was used to measure the LDH according to the manufacturer's instructions. Medium collected from cells without treatment was used as a control. The same treatment was repeated for three times. The untreated group was used as an isosmotic control treated with phosphate-buffered saline (PBS) only.
Cell viability experiments Propidium iodide and annexin V staining. Cells (1 Â 10 6 ) were collected after they had been treated with various concentrations of mIL-20R1a for the indicated times periods. Mitomycin C-treated cells were used as a positive control. The untreated group was used as an isosmotic control treated with PBS only. After annexin V labeling and propidium iodide staining, we used flow cytometry to assess the apoptotic effects of mIL-20R1a on M-1 and TKPTS cells as previously described. 
52
CaOx endocytosis experiments Calcium oxalate endocytosis was determined using flow cytometry at 488 nm excitation as previously described. 53 In brief, the flow cytometer detects how cells scatter the incident light from a focused laser beam and emit fluorescence. In forward-scatter, the light is diffracted at low angles, generally proportional to cell size. In sidescatter, the light is reflected at high angles, proportional to cell granularity and complexity, and detected at 901 to the incident light axis. Cultures of M-1 and TKPTS cells were treated with CaOx (66.7 mg cm
À2
) with or without mIL-20R1a (200 and 400 ng ml cells from each sample. Histograms of the light intensity were constructed for each experiment, and the geometric mean of the light intensity of the cell population was determined. CaOx crystals were excluded from analysis using a gated analysis method Detrimental roles of mIL-20R1a in calcium deposits C-C Wei and M-S Chang based on forward and side light-scatter. M-1 and TKPTS complexity (granularity) were considered control parameters and compared with the complexity of the cells after CaOx treatment.
Determining the rate of ROS production A dichlorofluorescein (DCF) assay was carried out to measure the rate of ROS production. To evaluate how mIL-20R1a affected ROS production in CaOx-stimulated M-1 and TKPTS cells, cells (1.5 Â 10 4 per well) seeded in a 96-well plate were pretreated with the non-polar, non-fluorescent 2 0 ,7 0 -dichlorodihydro-fluorescein diacetate (H 2 DCFDA), which is deacetylated by cytosolic esterases to form the polar, non-fluorescent dichlorodihydrofluorescein (DCFH). By reacting with ROS, DCFH gives rise to the fluorescence derivative DCF. A stock solution of H 2 DCFDA (5.0 mM) was prepared in absolute ethanol and stored at -20 1C. Immediately, before being treated with mIL-20R1a, the cell cultures were incubated with 10 mM of H 2 DCFDA in serum-free DMEM-F12 medium for 60 min at 37 1C. Then, the cells were treated with 133.4 mg cm À2 of CaOx or mIL-20R1a (200 ng ml À1 ), or both. The untreated group was used as an isosmotic control treated with PBS only. The fluorescence readings were taken immediately after treatment. Fluorescence was recorded in a microplate reader over time as indicated after excitation at 485 nm and emission at 535 nm. The treatment was repeated for five times.
Real-time PCR M-1 and TKPTS cells (2 Â 10 6 cells ml
À1
) were starved for 16 h before being treated with various stimuli-CaOx (133.4 mg cm À2 ) with or without mIL-20R1a (200 ng ml À1 ) or mIL-20R1a alone-for 4 h. The untreated group was used as an isosmotic control treated with PBS only. Total RNA was extracted using an RNA reagent (Trizol; Invitrogen) and cDNAs were synthesized using a reverse transcriptase (PowerScript, Clontech Laboratories, Palo Alto, CA, USA) according to the manufacturer's instructions. Detection of different gene transcripts was accomplished with SYBR Green I (Bio-Rad, Hercules, CA, USA) and gene-specific primers using an MJ Research DNA Engine Opticon 2 fluorescence detection system (MJ Research Inc., South San Francisco, CA, USA) as previously described. 23 Mouse GAPDH was used as an internal control gene to normalize for cDNA amounts. Real-time PCR data were analyzed using the comparative threshold cycle (C t ) method according to the manufacturer's instructions.
Analyzing kidneys from FvB control mice and mIL-20R1a transgenic mice Real-time PCR. Kidneys were collected from mIL-20R1a transgenic mice and FvB control mice. Total RNA was extracted from the kidneys and followed by reverse transcription with a random hexamer. The expression of nephrolithiasis-associated mediators was determined using real time-PCR with specific primers as previously described.
Immunohistochemical
staining. Immunohistochemical staining was used to confirm mIL-20R1a and MCP-1 expression in the kidneys from the FvB control mice and mIL-20R1a transgenic mice as previously described. 54 
Statistical analysis
Values presented are means ± s.d. Individual experimental group means were compared with control means using Student's t-test. Po0.05 was considered statistically significant.
